Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3406]

Decoding the risk of thromboembolic events in lymphoma patients

Prof Darko Antic - Clinic For Hematology, Clinical Center Serbia, Belgrade...

Decoding the risk of thromboembolic events in lymphoma patients ( Prof Darko Antic - Clinic For Hematology, Clinical Center Serbia, Belgrade, Serbia )

SGN-CD33A combined with HMA therapy produces high remission rates among older...

Dr Amir Fathi - Massachusetts General Hospital, Boston, USA

SGN-CD33A combined with HMA therapy produces high remission rates among older patients with AML ( Dr Amir Fathi - Massachusetts General Hospital, Boston, USA )

Killer antibodies against AML

Dr Mette Hazenberg - AMC, Amsterdam, The Netherlands

Killer antibodies against AML ( Dr Mette Hazenberg - AMC, Amsterdam, The Netherlands )

SL401 in patients with rare neoplasm

Prof Naveen Pemmaraju - The University of Texas MD Anderson Cancer Center...

SL401 in patients with rare neoplasm ( Prof Naveen Pemmaraju - The University of Texas MD Anderson Cancer Center, Houston, United States )

Blinatumomab improves survival in ALL patients

Prof Max Topp - University of Würzburg, Würzburg, Germany

Blinatumomab improves survival in ALL patients ( Prof Max Topp - University of Würzburg, Würzburg, Germany )

Stopping tyrosine kinase inhibitors in CML

Dr Johan Richter - Lund University, Sweden

Stopping tyrosine kinase inhibitors in CML ( Dr Johan Richter - Lund University, Sweden )

Evaluation of ibrutinib in treatment of CLL with 17p deletion

Dr Jeffrey Jones - OSU James Cancer Hospital, Columbus, USA

Evaluation of ibrutinib in treatment of CLL with 17p deletion ( Dr Jeffrey Jones - OSU James Cancer Hospital, Columbus, USA )

Nivolumab restores effective anti-tumour response in Hodgkin lymphoma

Dr Anas Younes - Memorial Sloan Kettering Cancer Centre, New York, USA

Nivolumab restores effective anti-tumour response in Hodgkin lymphoma ( Dr Anas Younes - Memorial Sloan Kettering Cancer Centre, New York, USA )

ASCO 2016: Current treatment approaches for advanced prostate cancer

Prof Przemyslaw Twardowski and Prof Gordon McVie

ASCO 2016: Current treatment approaches for advanced prostate cancer ( Prof Przemyslaw Twardowski and Prof Gordon McVie )

The value and strategy for incorporating biosimilars Into clinical practice

Dr Francisco Esteva - New York University, New York, USA

The value and strategy for incorporating biosimilars Into clinical practice ( Dr Francisco Esteva - New York University, New York, USA )

Checkpoint inhibitor therapy benefits advanced bladder cancer patients

Dr Arjun Vasant Balar - NYU Langone Medical Center, New York, USA

Checkpoint inhibitor therapy benefits advanced bladder cancer patients ( Dr Arjun Vasant Balar - NYU Langone Medical Center, New York, USA )

Neuroblastoma outcomes improved with second stem cell transplant

Dr Julie Park - Seattle Children's Hospital, Seattle, USA

Neuroblastoma outcomes improved with second stem cell transplant ( Dr Julie Park - Seattle Children's Hospital, Seattle, USA )

More from ecancer